Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2025-12-25 @ 12:32 AM
NCT ID:
NCT01138267
Eligibility Criteria:
Inclusion Criteria:
Inclusion criteria for pharmacogenomic of ATV:
1. On low-dose ATV/r at the time blood samples are collected for ATV drug levels
2. Age \> 18 years of age or older with HIV-1 infection
3. Provided consent form
Inclusion criteria for pharmacogenomic of EFV:
* On EFV at the time blood samples are collected for EFV levels
* Age \> 18 years of age or older with HIV-1 infection
* Patients who were on EFV but later switched to another ARV regimen due to toxicity of EFV and have stored sample at time of taking EFV
* Provided consent form
Exclusion Criteria:
Exclusion criteria for both ATV and EFV
1. Inability to understand the nature and extent of the study and the procedures required.
2. Contramedication such as rifampin, proton pump inhibitor (for ATV), etc
3. Pregnancy during blood drawn for EFV or ATV drug levels
4. Known renal insufficiency or cirrhosis during blood drawn for EFV or ATV drug levels
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01138267
Study Brief:
Protocol Section:
NCT01138267